disulfiram and glutathione Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines Drug Delivery Systems Frontiers | Disulfidptosis and androgenic
Description
The disease is characterized by subnormal ALP levels and elevated PLP and phosphoethanolamine levels
71.4% of patients (5 out of 7) achieved more than 10% scalp area regrowth
Patients are randomly assigned to treatment or placebo groups, and neither patients nor evaluators know who received which (double-blind)
Pay close attention to the following warning signs: Cloudiness or a hazy appearance in the liquid
